TransEnterix, Inc. (AMEX:TRXC) was founded in 2006 and is headquartered in Morrisville, North Carolina, USA, with 119 full-time employees. It is a medical device and supplies company dedicated to research, development and sales of medical device robots to strengthen Minimally invasive surgery.
TransEnterix, Inc. (TRXC):
TransEnterix is a medical device company that pioneered the use of robots to improve minimally invasive surgery by solving the clinical and economic challenges associated with current laparoscopy and robotic options in today’s value-based healthcare environment.
TransEnterix is focused on the commercialization of Senhance™ Surgical Robotic System, a multi-port robotic surgery system that can bring the advantages of robotic surgery to patients while enabling surgeons to use tactile feedback and Innovative technologies such as eye-sensing camera control.
In addition, TransEnterix has also developed the SPIDER device and SurgiBot System, a single-port, robot-enhanced laparoscopic surgery platform.
The Senhance™ surgical robot system can be sold in the United States, the European Union and other countries.